ArticleClinical and molecular hepatology2024

Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on "Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease".

So Jung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.